ESC 365 - Last step on the ladder: proprotein convertase subtilisin/kexin type 9 (PCSK9).

Open Access

Last step on the ladder: proprotein convertase subtilisin/kexin type 9 (PCSK9).

Session: Are we prepared to reduce LDL-cholesterol at any cost?

Topic: Drug therapy

Speaker: Professor L. Tokgozoglu (Ankara, TR)

Sponsored by Mylan

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Lale Tokgozoglu

Hacettepe University, Ankara (Türkiye)

44 presentations

8 followers

4 more presentations in this session

Challenges for reaching LDL-C goals in high and very high risk patients.

Speaker: Professor L. Tokgozoglu (Ankara, TR)

High potency statins and beyond: benefits of combination therapy.

Speaker: Doctor M. Farnier (Dijon, FR)

Cost implications of misunderstanding statin intolerance.

Speaker: Professor E. Stroes (Amsterdam, NL)

Conclusion - Are we prepared to reduce LDL-cholesterol at any cost?

Speaker: Professor L. Tokgozoglu (Ankara, TR)

Access the full session

Are we prepared to reduce LDL-cholesterol at any cost?

Speakers: Professor L. Tokgozoglu, Professor L. Tokgozoglu, Doctor M. Farnier, Professor E. Stroes, Professor L. Tokgozoglu

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources